These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 7916041)

  • 1. Effect of granulocyte-macrophage colony-stimulating factor on oral mucositis after hematopoietic stem-cell transplantation.
    Gordon B; Spadinger A; Hodges E; Ruby E; Stanley R; Coccia P
    J Clin Oncol; 1994 Sep; 12(9):1917-22. PubMed ID: 7916041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of granulocyte-macrophage colony-stimulating factor on oral mucositis in head and neck cancer patients after cisplatin, fluorouracil, and leucovorin chemotherapy.
    Chi KH; Chen CH; Chan WK; Chow KC; Chen SY; Yen SH; Chao JY; Chang CY; Chen KY
    J Clin Oncol; 1995 Oct; 13(10):2620-8. PubMed ID: 7595716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of locally applied GM-CSF on oral mucositis after stem cell transplantation: a prospective placebo-controlled double-blind study.
    van der Lelie H; Thomas BL; van Oers RH; Ek-Post M; Sjamsoedin SA; van Dijk-Overtoom ML; Timmer JG; von dem Borne AE
    Ann Hematol; 2001 Mar; 80(3):150-4. PubMed ID: 11320899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Four-step high-dose sequential chemotherapy with double hematopoietic progenitor-cell rescue for metastatic breast cancer.
    Patrone F; Ballestrero A; Ferrando F; Brema F; Moraglio L; Valbonesi M; Basta P; Ghio R; Gobbi M; Sessarego M
    J Clin Oncol; 1995 Apr; 13(4):840-6. PubMed ID: 7707109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Palifermin reduces patient-reported mouth and throat soreness and improves patient functioning in the hematopoietic stem-cell transplantation setting.
    Stiff PJ; Emmanouilides C; Bensinger WI; Gentile T; Blazar B; Shea TC; Lu J; Isitt J; Cesano A; Spielberger R
    J Clin Oncol; 2006 Nov; 24(33):5186-93. PubMed ID: 16391299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of granulocyte-macrophage colony-stimulating factor on chemotherapy-induced oral mucositis in non-neutropenic cancer patients.
    Ibrahim EM; al-Mulhim FA
    Med Oncol; 1997 Mar; 14(1):47-51. PubMed ID: 9232612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylaxis with GM-CSF mouthwashes does not reduce frequency and duration of severe oral mucositis in patients with solid tumors undergoing high-dose chemotherapy with autologous peripheral blood stem cell transplantation rescue: a double blind, randomized, placebo-controlled study.
    Dazzi C; Cariello A; Giovanis P; Monti M; Vertogen B; Leoni M; Tienghi A; Turci D; Rosti G; Nanni O; Rondoni C; Marangolo M
    Ann Oncol; 2003 Apr; 14(4):559-63. PubMed ID: 12649101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Granulocyte macrophage-colony stimulating factor and oral mucositis.
    Fung SM; Ferrill MJ
    Ann Pharmacother; 2002 Mar; 36(3):517-20. PubMed ID: 11895067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of oral mucositis in patients receiving hematopoietic cell transplants for chronic myelogenous leukemia.
    Robien K; Schubert MM; Bruemmer B; Lloid ME; Potter JD; Ulrich CM
    J Clin Oncol; 2004 Apr; 22(7):1268-75. PubMed ID: 15051775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II clinical trial of local use of GM-CSF for prevention and treatment of chemotherapy- and concomitant chemoradiotherapy-induced severe oral mucositis in advanced head and neck cancer patients: an evaluation of effectiveness, safety and costs.
    Mantovani G; Massa E; Astara G; Murgia V; Gramignano G; Lusso MR; Camboni P; Ferreli L; Mocci M; Perboni S; Mura L; Madeddu C; Macciò A
    Oncol Rep; 2003; 10(1):197-206. PubMed ID: 12469169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Granulocyte-macrophage colony-stimulating factor (GM-CSF) priming of high-dose etoposide and cyclophosphamide: a pilot trial.
    Bernstein SH; Christiansen NP; Fay JP; Brown R; Herzig R; Frankel S; Blumenson L; Herzig GP
    Exp Hematol; 1996 Oct; 24(12):1363-8. PubMed ID: 8913281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells.
    Carlo-Stella C; Regazzi E; Andrizzi C; Savoldo B; Garau D; Montefusco E; Vignetti M; Mandelli F; Rizzoli V; Meloni G
    Haematologica; 1997; 82(3):291-6. PubMed ID: 9234574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized double-blind prospective trial to evaluate the effects of sargramostim versus placebo in a moderate-dose fluorouracil, doxorubicin, and cyclophosphamide adjuvant chemotherapy program for stage II and III breast cancer.
    Jones SE; Schottstaedt MW; Duncan LA; Kirby RL; Good RH; Mennel RG; George TK; Snyder DA; Watkins DL; Denham CA; Hoyes FA; Rubin AS
    J Clin Oncol; 1996 Nov; 14(11):2976-83. PubMed ID: 8918495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of granulocyte-macrophage colony-stimulating factor on prevention of mucositis in head and neck cancer patients treated with chemo-radiotherapy.
    Rosso M; Blasi G; Gherlone E; Rosso R
    J Chemother; 1997 Oct; 9(5):382-5. PubMed ID: 9373795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local application of granulocyte-macrophage colony stimulating factor (GM-CSF) for the treatment of oral mucositis.
    Sprinzl GM; Galvan O; de Vries A; Ulmer H; Gunkel AR; Lukas P; Thumfart WF
    Eur J Cancer; 2001 Nov; 37(16):2003-9. PubMed ID: 11597377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Granulocyte-macrophage colony-stimulating factor given before dose-intensive cyclophosphamide, etoposide, and cisplatin (DICEP).
    Holdsworth MT; Roon R; Ferguson J; Martinez L; Stidley CA; Neidhart JA
    Biotechnol Ther; 1993; 4(3-4):183-95. PubMed ID: 8292969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I trial of thiotepa in combination with recombinant human granulocyte-macrophage colony-stimulating factor.
    O'Dwyer PJ; LaCreta FP; Schilder R; Nash S; McAleer C; Miller LL; Hudes GR; Ozols RF
    J Clin Oncol; 1992 Aug; 10(8):1352-8. PubMed ID: 1634926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ifosfamide, carboplatin, and etoposide plus granulocyte-macrophage colony-stimulating factor: a phase I study with apparent activity in non-small-cell lung cancer.
    Krigel RL; Palackdharry CS; Padavic K; Haas N; Kilpatrick D; Langer C; Comis R
    J Clin Oncol; 1994 Jun; 12(6):1251-8. PubMed ID: 8201386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of concurrent granulocyte macrophage-colony stimulating factor on radiation-induced mucositis in head and neck cancer patients: a double-blind placebo-controlled prospective phase III study by Radiation Therapy Oncology Group 9901.
    Ryu JK; Swann S; LeVeque F; Scarantino CW; Johnson D; Chen A; Fortin A; Pollock J; Kim H; Ang KK
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):643-50. PubMed ID: 17293228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemoradiotherapy with or without granulocyte-macrophage colony-stimulating factor in the treatment of limited-stage small-cell lung cancer: a prospective phase III randomized study of the Southwest Oncology Group.
    Bunn PA; Crowley J; Kelly K; Hazuka MB; Beasley K; Upchurch C; Livingston R; Weiss GR; Hicks WJ; Gandara DR
    J Clin Oncol; 1995 Jul; 13(7):1632-41. PubMed ID: 7602352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.